3DTECH OY

Their core work

3DTECH OY is a Finnish SME specializing in advanced 3D printing and additive manufacturing technologies. They provide expertise in processing thermoplastic and cellulose-based materials through 3D printing, foam forming, and thermoforming techniques for industrial applications. Their work spans from manufacturing electrical insulation components using bio-based materials to bioprinting smart nanobiomaterial matrices for medical applications, positioning them at the intersection of industrial manufacturing and biomedical engineering.

What they specialise in

How they've shifted over time

With all three projects starting between 2017 and 2019, 3DTECH's H2020 portfolio shows a rapid broadening rather than a linear shift. Their involvement moved from training-network participation (PRINT-AID, 2017) to direct industrial piloting of cellulose-based 3D printing (NOVUM, 2017) and then into biomedical 3D printing with smart nanomaterials (RESTORE, 2019). The trajectory shows a company that started with industrial additive manufacturing and progressively applied its 3D printing know-how to increasingly complex biomedical contexts.

3DTECH is moving from purely industrial additive manufacturing toward biomedical applications, suggesting future collaborations should consider them for projects bridging manufacturing processes with health-tech or regenerative medicine.

How they like to work

3DTECH has never coordinated an H2020 project, consistently joining as participant or third party — typical for a specialist SME that contributes targeted technical capabilities rather than managing large consortia. Despite their small size, they have worked with 38 unique partners across 15 countries, indicating openness to diverse international teams. Their involvement across three different funding schemes (MSCA-ITN, RIA, IA) suggests adaptability to different project structures and consortium sizes.

Despite only three projects, 3DTECH has built a notably wide network of 38 partners across 15 countries, reflecting participation in large European consortia spanning both industrial and biomedical research communities.

What sets them apart

3DTECH's distinctive value lies in their ability to apply 3D printing and additive manufacturing across very different domains — from cellulose-based industrial components to bioprinted cartilage repair matrices. This cross-domain versatility is rare among specialist SMEs, which typically stay within one application area. For consortium builders, they offer a practical 3D printing partner who can adapt their manufacturing expertise to both traditional industrial and advanced biomedical contexts.

Highlights from their portfolio

• NOVUM
  Pilot-line project applying 3D printing to cellulose-based electrical insulation — an unusual combination of bio-based materials with industrial manufacturing at scale.
• RESTORE
  Crosses from industrial 3D printing into biomedical territory, working on stimuli-responsive nanobiomaterial matrices for cartilage regeneration — demonstrating the company's cross-domain reach.